Table 1.

Demographic data from included trials for meta-analysis (N-23).

Variable	No. of Trials (%)
Publication year 2000–2022	23
Region of research Americas USA Canada Brazil Europe Germany Sweden Netherlands Spain Switzerland UK Asia India South Korea Australia	7 [31] 5 1 1 11 [47] 5 2 1 1 1 1 2 [9] 1 1 3 [13]
Sample size ≤50 51–100 ≥101	4 [24] 12 [48] 7 [28]
No. of participants Group Allocation Exercise Control	1954 (100.0) 1087 [56] 867 [44]
Mean age years (SD)	58.4 (8.3)
Female sex	1520 [74]
Cancer site Breast Head, neck and oral Prostate Leukemia Lung Pancreatic Mixed	10 [44] 2 [12] 2 [8] 1 [4] 1 [4] 1 [4] 6 [24]
Exercise type Aerobic & resistance Aerobic alone Resistance alone	10 [44] 7 [30] 6 [26]
Clinical settings Oncology outpatient clinic Hospital inpatient	24 [75] 1 [4]